Stephens Investment Management Group’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $39.2M | Sell |
|
|||||
|
2024
Q1 | $41.7M | Buy |
|
|||||
|
2023
Q4 | $44.5M | Sell |
|
|||||
|
2023
Q3 | $41.2M | Buy |
|
|||||
|
2023
Q2 | $53.6M | Buy |
|
|||||
|
2023
Q1 | $47.8M | Buy |
|
|||||
|
2022
Q4 | $45.5M | Sell |
|
|||||
|
2022
Q3 | $62.2M | Buy |
|
|||||
|
2022
Q2 | $68.1M | Buy |
|
|||||
|
2022
Q1 | $88.5M | Buy |
|
|||||
|
2021
Q4 | $68.5M | Buy |
|
|||||
|
2021
Q3 | $54.6M | Buy |
|
|||||
|
2021
Q2 | $58.1M | Sell |
|
|||||
|
2021
Q1 | $68.1M | Buy |
|
|||||
|
2020
Q4 | $58M | Sell |
|
|||||
|
2020
Q3 | $60M | Sell |
|
|||||
|
2020
Q2 | $53.9M | Sell |
|
|||||
|
2020
Q1 | $41.6M | Sell |
|
|||||
|
2019
Q4 | $57.1M | Sell |
|
|||||
|
2019
Q3 | $48.1M | Buy |
|
|||||
|
2019
Q2 | $52.6M | Buy |
|
|||||
|
2019
Q1 | $45.7M | Buy |
|
|||||
|
2018
Q4 | $51.6M | Sell |
|
|||||
|
2018
Q3 | $60.4M | Buy |
|
|||||
|
2018
Q2 | $37.2M | Buy |
|
|||||
|
2018
Q1 | $32.8M | Buy |
|
|||||
|
2017
Q4 | $46.4M | Buy |
|
|||||
|
2017
Q3 | $37.8M | Buy |
|
|||||
|
2017
Q2 | $45M | Buy |
|
|||||
|
2017
Q1 | $40.9M | Buy |
|
|||||
|
2016
Q4 | $24.3M | Buy |
|
|||||
|
2016
Q3 | $21.2M | Buy |
|
|||||
|
2016
Q2 | $19.5M | Sell |
|
|||||
|
2016
Q1 | $30.8M | Buy |
|
|||||
|
2015
Q4 | $41.5M | Buy |
|
|||||
|
2015
Q3 | $20.2M | Buy |
|
|||||
|
2015
Q2 | $29.5M | Buy |
|
|||||
|
2015
Q1 | $36.5M | Sell |
|
|||||
|
2014
Q4 | $39.2M | Sell |
|
|||||
|
2014
Q3 | $43.2M | Buy |
|
|||||
|
2014
Q2 | $38.2M | Sell |
|
|||||
|
2014
Q1 | $34.9M | Sell |
|
|||||
|
2013
Q4 | $29.1M | Sell |
|
|||||
|
2013
Q3 | $30.6M | Buy |
|
|||||
|
2013
Q2 | $13.4M | Buy |
|